United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus

Annals of Internal Medicine

Volumn 124, Issue 1 II, 1996, Pages 136-145

  Turner, Robert ^a   Cull, Carole ^a   Holman, Rury ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CAPTOPRIL; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIPIZIDE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; METFORMIN;

ADULT; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC DIET; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030034518     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_2-199601011-00011     Document Type: Conference Paper

References (42)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population Sixteen year follow-up study Diabetes 1974,23:105-11
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 1993;16:434-44
3. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 1987,30 123-31
4. Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD. Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 1994;11.968-73
5. Panzram G, Zabel-Langhennig R. Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 1981,20.587-91.
6. Laing W, Williams DR. Diabetes, A Model for Health Care Management London. Office of Health Economics, 1989. no 92.32-49
7. Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes VII. Mortality and selected nonfatal events with insulin treatment JAMA 1978;240:37-42.
8. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988,318 1315-21.
9. +-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 1988,37 688-93
10. Nathan DM. Inferences and implications Do results from the Diabetes Control and Complications Trial apply in NIDDM? Diabetes Care 1995,18 251-7
11. Jarrett RJ, Keen H. Hyperglycaemia and diabetes mellitus Lancet 1976, 2 1009-12
12. Pettitt DJ, Knowler WC, Lisse JR, Bennett PH. Development of retinopathy and proteinuria in relation to plasma-glucose concentration in Pima Indians Lancet 1980,2:1050-2
13. WHO Study Group on Diabetes Mellitus. Diabetes mellitus report of a WHO study group Geneva World Health Organization, 1985 WHO technical report series no 727
14. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance The Whitehall study Lancet 1980,1 1373-6
15. Eschwège E, Richard JL, Thibult N, Ducimetière P, Warnet JM, Claude JR, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res Suppl 1985,15:41-6
16. Stamler R, Stamler J. Asymptomatic hyperglycaemia and coronary heart disease. A series of papers by the International Collaborative Group based on studies in fifteen populations J Chron Dis. 1979;32:683-837.
17. Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetiere P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes Results from the 11-year follow-up of the Paris Prospective Study Diabetologia. 1989, 32 300-4
18. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up Diabetologia 1991,34 356-61
19. Reaven GM. Banting lecture 1988 Role of insulin resistance in human disease Diabetes 1988;37 1595-607.
20. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 1994,43: 960-7.
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993,329:977-86.
22. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes II Mortality results. Diabetes 1970,19(Suppl 2):789-830
23. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes V Evaluation of phenformin therapy Diabetes 1975;24(Suppl 1):65-184
24. Ashford ML, Bond CT, Blair TA, Adelman JP. Cloning and functional expression of a rat heart K-ATP channel. Nature 1994;370 456-9
25. Pogátsa G, Koltai MZ, Jermendy G, Simon J, Aranyi Z, Ballagi-Pordany G. The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients Acta Med Hung 1992-93,49:39-51.
26. Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G. Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds Diabetes Res Clin Pract 1990;8 109-14
27. Stout RW. Insulin and atherosclerosis In Stout RW, ed Diabetes and Atherosclerosis. Dordrecht, the Netherlands Kluwer Academic Publishers, 1992 165-201.
28. Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P. Glucose tolerance and coronary heart disease: Helsinki policemen study J Chronic Dis 1979;32:729-45.
29. Ducimetière P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population Diabetologia. 1980,19:205-10.
30. Jarrett RJ. Is insulin atherogenic? Diabetologia 1988;31:71-5.
31. UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress and performance Diabetologia 1991;34:877-90.
32. United Kingdom Prospective Diabetes Study (UKPDS). 13 Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years BMJ 1995;310: 83-8
33. UK Prospective Diabetes Study (UKPDS). 16: Overview of 6 years' therapy of a progressive disease UK Prospective Diabetes Group Diabetes 1995 [In press ]
34. Metropolitan Life Insurance Company. New weight standard for men and women Statistical Bulletin Metropolitan Life. 1959,40 1-4
35. UK Prospective Diabetes Study (UKPDS) XII Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes UK Prospective Diabetes Study Group Diabet Med 1994,11 670-7.
36. UK Prospective Diabetes Study 7 response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group. Metabolism 1990 39 905-12
37. Holman RR, Turner RC. Diabetes the quest for basal normoglycaemia Lancet 1977,1 469-74
38. Holman RR, Turner RC. A practical guide to basal and prandial insulin therapy Diabet Med 1985,2 45-53.
39. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28 412-9
40. Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus A multicenter controlled clinical trial Ann Intern Med 1994,121 928-35
41. Hypertension in Diabetes Study (HDS) II Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients J Hypertens. 1993,11. 319-25
42. Hypertension in Diabetes Study III Prospective study of therapy of hypertension in type 2 diabetic patients: efficacy of ACE inhibition and beta-blockade Diabet Med 1994,11 773-82